Bliss GVS Pharma Limited (BLISSGVS.NS)
INR 169.0
(0.87%)
INR 169.0
(0.87%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 998.4 Million INR | -2.02% |
| 2022 | 1.01 Billion INR | -6.85% |
| 2021 | 1.09 Billion INR | -10.26% |
| 2020 | 1.21 Billion INR | -3.35% |
| 2019 | 1.26 Billion INR | 23.73% |
| 2018 | 1.01 Billion INR | -13.58% |
| 2017 | 1.17 Billion INR | -36.94% |
| 2016 | 1.87 Billion INR | 86.37% |
| 2015 | 1 Billion INR | -15.16% |
| 2014 | 1.18 Billion INR | -18.21% |
| 2013 | 1.44 Billion INR | -6.84% |
| 2012 | 1.55 Billion INR | 312.6% |
| 2011 | 376.29 Million INR | 356.7% |
| 2010 | 82.39 Million INR | 7.82% |
| 2009 | 76.42 Million INR | 216.48% |
| 2008 | 24.14 Million INR | -30.92% |
| 2007 | 34.95 Million INR | -54.2% |
| 2006 | 76.31 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 832.88 Million INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 998.4 Million INR | -2.02% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 995.53 Million INR | 0.0% |
| 2023 Q4 | 998.4 Million INR | 0.0% |
| 2022 FY | 1.01 Billion INR | -6.85% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 1.02 Billion INR | 0.0% |
| 2022 Q4 | 1.01 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q4 | 1.09 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 1.01 Billion INR | 0.0% |
| 2021 FY | 1.09 Billion INR | -10.26% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 1.21 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 1.21 Billion INR | -3.35% |
| 2020 Q2 | 1.28 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 984.9 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 1.26 Billion INR | 23.73% |
| 2019 Q4 | 1.26 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 FY | 1.01 Billion INR | -13.58% |
| 2018 Q4 | 1.01 Billion INR | 0.0% |
| 2018 Q2 | 743.04 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q2 | 2.52 Billion INR | 0.0% |
| 2017 FY | 1.17 Billion INR | -36.94% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 1.11 Billion INR | 0.0% |
| 2016 FY | 1.87 Billion INR | 86.37% |
| 2016 Q4 | 1.87 Billion INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q2 | 762.22 Million INR | 0.0% |
| 2015 Q4 | 1 Billion INR | 0.0% |
| 2015 FY | 1 Billion INR | -15.16% |
| 2014 FY | 1.18 Billion INR | -18.21% |
| 2013 FY | 1.44 Billion INR | -6.84% |
| 2012 FY | 1.55 Billion INR | 312.6% |
| 2012 Q4 | 1.55 Billion INR | 0.0% |
| 2012 Q2 | 1.08 Billion INR | 0.0% |
| 2011 FY | 376.29 Million INR | 356.7% |
| 2010 FY | 82.39 Million INR | 7.82% |
| 2009 FY | 76.42 Million INR | 216.48% |
| 2008 FY | 24.14 Million INR | -30.92% |
| 2007 FY | 34.95 Million INR | -54.2% |
| 2006 FY | 76.31 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Sigachi Industries Limited | 1.43 Billion INR | 30.207% |
| Ind-Swift Limited | 10.13 Billion INR | 90.154% |
| Bajaj HealthCare Limited | 3.32 Billion INR | 70.002% |
| Sakar Healthcare Limited | 793.51 Million INR | -25.82% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 98.498% |
| Innova Captab Limited | 2.45 Billion INR | 59.266% |
| Divi's Laboratories Limited | 30 Million INR | -3228.003% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -2071.287% |
| Morepen Laboratories Limited | 289.99 Million INR | -244.286% |
| Mankind Pharma Limited | 2.07 Billion INR | 51.808% |
| Sequent Scientific Limited | 4.87 Billion INR | 79.528% |
| Wanbury Limited | 1.16 Billion INR | 14.289% |
| Laurus Labs Limited | 25.77 Billion INR | 96.126% |
| Nectar Lifesciences Limited | 6.35 Billion INR | 84.29% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -482.226% |
| Alembic Limited | 91.5 Million INR | -991.149% |
| Hikal Limited | 8.17 Billion INR | 87.788% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | 80.544% |
| Neuland Laboratories Limited | 953.89 Million INR | -4.666% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 73.563% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 91.889% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -204.762% |
| Themis Medicare Limited | 957.92 Million INR | -4.226% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Zydus Lifesciences Limited | 8.04 Billion INR | 87.585% |
| Lupin Limited | 29.21 Billion INR | 96.583% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -5676.781% |
| Wockhardt Limited | 23.56 Billion INR | 95.762% |
| Vaishali Pharma Limited | 134.91 Million INR | -640.006% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | 64.999% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -1016.655% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 97.275% |
| FDC Limited | 205.18 Million INR | -386.586% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 95.013% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -215.485% |
| Eris Lifesciences Limited | 27.81 Billion INR | 96.41% |
| Venus Remedies Limited | 413.3 Million INR | -141.568% |
| ZIM Laboratories Limited | 1.08 Billion INR | 8.256% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 19.7 Million INR | -4968.025% |
| Shilpa Medicare Limited | 9.37 Billion INR | 89.349% |
| Albert David Limited | 33.24 Million INR | -2903.432% |
| Ajanta Pharma Limited | 352.8 Million INR | -182.993% |
| Hester Biosciences Limited | 2.44 Billion INR | 59.145% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -53.609% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | 90.13% |
| Gufic Biosciences Limited | 3.32 Billion INR | 70.01% |
| Windlas Biotech Limited | 36.41 Million INR | -2642.107% |
| Procter & Gamble Health Limited | 95.6 Million INR | -944.353% |
| Aarey Drugs & Pharmaceuticals Limited | 313.52 Million INR | -218.446% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -1.368% |
| Granules India Limited | 13.15 Billion INR | 92.408% |
| Aarti Drugs Limited | 5.64 Billion INR | 82.306% |
| Bal Pharma Limited | 1.39 Billion INR | 28.506% |
| Alkem Laboratories Limited | 14.18 Billion INR | 92.961% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 96.95% |
| Lincoln Pharmaceuticals Limited | 10.66 Million INR | -9258.84% |
| Medicamen Biotech Limited | 308.17 Million INR | -223.975% |
| Unichem Laboratories Limited | 2.47 Billion INR | 59.663% |
| Bafna Pharmaceuticals Limited | 243.89 Million INR | -309.36% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -22647.801% |
| Valiant Laboratories Limited | 767.08 Million INR | -30.155% |
| Orchid Pharma Limited | 1.35 Billion INR | 26.143% |
| Medico Remedies Limited | 80.5 Million INR | -1140.188% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -500.665% |
| Ipca Laboratories Limited | 14.38 Billion INR | 93.059% |
| Brooks Laboratories Limited | 56.41 Million INR | -1669.618% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -37.736% |
| Piramal Enterprises Limited | 535.85 Billion INR | 99.814% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 97.518% |
| NATCO Pharma Limited | 3.71 Billion INR | 73.103% |
| Suven Life Sciences Limited | 7.09 Million INR | -13967.93% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 48.384% |
| Strides Pharma Science Limited | 25.16 Billion INR | 96.033% |
| Indoco Remedies Limited | 6.71 Billion INR | 85.142% |
| Alpa Laboratories Limited | 52.46 Million INR | -1802.985% |
| Lasa Supergenerics Limited | 220.76 Million INR | -352.252% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -63.271% |